We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gene for Drug Abuse Identified

By Biotechdaily staff writers
Posted on 22 May 2002
Researchers have been able to identify a gene that increases risk for use and dependence on drugs. More...
In a study appearing in the March 2002 issue of the Journal of Molecular Psychiatry, they report that the mu-opoid gene brings about increased risk for use and abuse of drugs in general and does not appear to be specific for any particular drug.

The new study followed up on work done in 1999 that found a relationship between alcohol dependence and the mu-opoid gene. By comparing gene patterns between alcoholics and normal volunteers, they discovered that alcoholics had an abundance of a particular form of the mu-opioid gene, the AA form, compared to non-alcoholics. However, since many alcoholics included in the 1999 study were also abusers of other substances, the researchers could not conclude that this particular gene configuration conferred increased risk specific to alcoholism or to drug abuse in general.

"The 1999 study suggested that mu-opioid was a part of the drug abuse story, but did not allow us to ask more specific questions about relationships to other drugs or the gene's impact in other groups such as smokers or social drinkers,” said Dr. John Schinka, professor of psychiatry at the University of South Florida (Tampa, USA).
"In the current study, we looked at several groups, including a group of normal volunteers who had never been smokers or drinkers and a group of alcoholics who also used other drugs.”

The new research showed that the AA configuration occurred even in individuals with no history of smoking or drinking. However, the frequency of the configuration increased in groups with any use of alcohol or cigarettes and occurred in almost 90% of individuals treated for abuse of several drugs. Dr. Schinka emphasized that mu-opioid is only one of several genes that produce risk for drug abuse. The search for other genes will continue, and studies will also address how mu-opioid might interact with other genes in increasing risk.

University of South Florida >> www.usf.edu



Related Links:
University of South Florida

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.